Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medtronic (NY: MDT )

84.74 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
The Millennium Alliance Opens 2024 With Major Sponsor Commitments For Their Award-Winning Assemblies From Some of Tech's Biggest Players
Including Dell, Splunk, Medtronic, Trend Micro, GE Healthcare, IBM, Verizon, TCS, Palo Alto Networks and AWSNEW YORK - May 2, 2024 - PRLog -- The Millennium Alliance, an invitation-only organization... 
Via PRLog
Decoding Medtronic's Options Activity: What's the Big Picture?
Via Benzinga
Paying for Prestige: Medtop Award Explains if It Works in Healthcare Awards
Via Get News
Cloud DX Reports Significant Revenue and Profit Growth in 2023
Cloud DX Reports Significant Revenue and Profit Growth in 2023 
Via News Direct
Cloud DX Reports Significant Revenue and Profit Growth in 2023
Cloud DX CEO Robert Kaul joined Steve Darling from Proactive to discuss the company's impressive performance in its 2023 full-year results. Notably, Cloud DX reported a substantial 55.4% increase in... 
Via TheNewswire.com
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
With digital intelligence having the capability of advancing care, these are the medical AI stocks that long-term investors should consider. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Looking Into Medtronic's Recent Short Interest
Via Benzinga
Medtronic Stock: Buy, Sell, or Hold?
Can this struggling healthcare specialist turn things around? 
Via The Motley Fool
Intuitive Surgical Leads the Robotic Surgery Movement
Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays
Discover why it might be time to trade dividend aristocrats for companies with aggressive buyback strategies for better capital gains. 
Via InvestorPlace
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in... 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end? 
Via Investor's Business Daily
7 Dividend Stocks to Buy Now for Decades of Consistent Returns
These dividend stocks combine solid yield and income alongside long-term capital appreciation opportunities. 
Via InvestorPlace
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income. 
Via The Motley Fool
Here Are My Top Artificial Intelligence (AI) Stocks to Buy Now
These three players offer you a great entry point right now. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic (NYSE: MDT). "I like what they’re doing in AI. 
Via Benzinga
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:MDT),(NASDAQ:NVDA),(NASDAQ:LTRN),(OTCQX:HWAIF),(TSX:AIDX) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
Via AB Newswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People 
Via MarketBeat
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
Which dividend-paying healthcare stock is better positioned to produce a rapidly growing payout? 
Via The Motley Fool
2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets
There are many ways to cash in on the rise of AI. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Smartest Dividend Stocks to Buy With $400 Right Now
Dividend-payers aren't just for your grandparents -- they actually outperform non-payers, according to one study. 
Via The Motley Fool
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential... 
Via Benzinga
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
FDA approves Medtronic's Evolut FX+ TAVR system for severe aortic stenosis. Enhanced coronary access, maneuverability for diverse anatomies. Early Commercial Experience in spring 2024. 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.